Independent confirmation of preclinical findings, typically conducted by a contract research organization or other third-party laboratory unaffiliated with the company's own internal research team, adds meaningful credibility to a drug candidate's underlying scientific rationale. It reduces the risk that observed anti-tumor effects were specific …
The offering involves the sale of 8,571,429 common shares along with equivalent warrants, priced at a unit price of $1.05. Given the stock's closing price of $0.89, the offering was priced at a level above where the stock ultimately settled, though the exact relationship …
The core value proposition of this new tool is its ability to facilitate expedited screening and prioritization of fungicide leads based solely on chemical architecture. Traditional agrochemical discovery typically requires extensive laboratory testing to assess how candidate compounds interact with target fungal pathogens, a …
These patent actions, issued across key international markets including the United States, Canada, and Japan, bring Phio's total issued patent portfolio to 54 patents — a substantial intellectual property estate for a clinical-stage biotech company of Phio's size. The robust IP package comprehensively covers …
The catalyst for the day's volatility was another round of US strikes against Iran, paired with the reinstatement of a naval blockade targeting Iranian ports near the Strait of Hormuz. US forces struck dozens of military assets along Iran's coastline and near the strategic …
Lucid's management responded to Tuesday's report with unusually forceful and multi-pronged pushback. The company explicitly called the bankruptcy and take-private rumors 'completely false,' language that leaves little room for ambiguity or partial confirmation. Beyond a simple public statement, Lucid escalated its response by issuing …
The fourth-quarter results themselves were striking on their own terms. Aehr posted non-GAAP earnings per share of $0.11, crushing the consensus estimate of negative $0.01 — a swing from an expected loss to an actual profit that represents a substantially larger beat than the …
US equities closed mixed on Wednesday as softer inflation data and strong financial-sector earnings offset weakness in semiconductor stocks. The S&P 500 gained 0.4% and the Dow rose 150 points, while the Nasdaq 100 slipped 0.3%. Lower-than-expected producer inflation reduced expectations of a near-term …
The US equity market delivered another rotational session on July 15, 2026, as investors shifted capital away from Technology and Utilities and toward Communication Services, Consumer Discretionary, and Financials. The strong performance of growth-oriented sectors suggests investor risk appetite remained healthy despite weakness in …
The latest Relative Rotation Graph (RRG) for July 15, 2026, highlights a further evolution in US sector leadership. Consumer Discretionary has rotated into the Lagging quadrant, joining Technology, Materials, Consumer Staples, and Real Estate among the market's underperformers. Meanwhile, Energy and Communication Services remain …